These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion. Nakada MT; Montgomery MO; Nedelman MA; Guerrero JL; Cohen SA; Barnathan ES; Jordan RE J Vasc Interv Radiol; 2004 Feb; 15(2 Pt 1):169-76. PubMed ID: 14963184 [TBL] [Abstract][Full Text] [Related]
6. Intra-arterial thrombolysis (reteplase) and ReoPro for subacute thrombosis of the distal aorta accomplished by radial arterial access: the radial-kissing-thrombolytic technique. de La Serna FA; Tolleson TR; Crowley JJ; Stack RS; Zidar JP Catheter Cardiovasc Interv; 2001 Jun; 53(2):264-8. PubMed ID: 11387618 [TBL] [Abstract][Full Text] [Related]
7. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. Lincoff AM; Califf RM; Van de Werf F; Willerson JT; White HD; Armstrong PW; Guetta V; Gibler WB; Hochman JS; Bode C; Vahanian A; Steg PG; Ardissino D; Savonitto S; Bar F; Sadowski Z; Betriu A; Booth JE; Wolski K; Waller M; Topol EJ; JAMA; 2002 Nov; 288(17):2130-5. PubMed ID: 12413372 [TBL] [Abstract][Full Text] [Related]
8. Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion. Al-Mufti F; Amuluru K; Manning NW; Khan I; Peeling L; Gandhi CD; Prestigiacomo CJ; Pushchinska G; Fiorella D; Woo HH Br J Neurosurg; 2017 Oct; 31(5):573-579. PubMed ID: 28298139 [TBL] [Abstract][Full Text] [Related]
9. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases. Kwon OK; Lee KJ; Han MH; Oh CW; Han DH; Koh YC AJNR Am J Neuroradiol; 2002 Mar; 23(3):447-51. PubMed ID: 11901016 [TBL] [Abstract][Full Text] [Related]
10. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation; 2000 Jun; 101(24):2788-94. PubMed ID: 10859283 [TBL] [Abstract][Full Text] [Related]
12. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Qureshi AI; Suri MF; Khan J; Fessler RD; Guterman LR; Hopkins LN Neurosurgery; 2000 Jun; 46(6):1316-24; discussion 1324-5. PubMed ID: 10834637 [TBL] [Abstract][Full Text] [Related]
13. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase. Merlini PA; Repetto A; Andreoli AM; Ricci S; Lombardi A; Finardi A; Dipasquale G; Lamponi M; Mannucci PM; Ardissino D Am J Cardiol; 2004 Jan; 93(2):195-8. PubMed ID: 14715345 [TBL] [Abstract][Full Text] [Related]
14. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Qureshi AI; Harris-Lane P; Kirmani JF; Janjua N; Divani AA; Mohammad YM; Suarez JI; Montgomery MO Neurosurgery; 2006 Oct; 59(4):789-96; discussion 796-7. PubMed ID: 16915119 [TBL] [Abstract][Full Text] [Related]
15. Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis. Szabo S; Etzel D; Ehlers R; Walter T; Kazmaier S; Helber U; Beyer ME; Hoffmeister HM Drugs Exp Clin Res; 2004; 30(2):47-54. PubMed ID: 15272642 [TBL] [Abstract][Full Text] [Related]
16. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction. Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430 [TBL] [Abstract][Full Text] [Related]
17. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123 [TBL] [Abstract][Full Text] [Related]
18. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Qureshi AI; Suri MF; Ali Z; Kim SH; Lanzino G; Fessler RD; Ringer AJ; Guterman LR; Hopkins LN Neurosurgery; 2002 Mar; 50(3):466-73; discussion 473-5. PubMed ID: 11841713 [TBL] [Abstract][Full Text] [Related]
19. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Topol EJ; Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410 [TBL] [Abstract][Full Text] [Related]
20. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. Drescher P; Crain MR; Rilling WS J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]